Skip to main content

Progenitor Cell Therapy to Evaluate Sistemic Technology

Premium

Sistemic, a microRNA profiling firm, said this week that it has signed a deal under which NeoStem subsidiary Progenitor Cell Therapy will evaluate its stem cell-characterization technology.

According to Sistemic, Progenitor will test the applicability of its miRNA profiling system and analytical approaches for stem cell characterization.

Additional terms of the arrangement were not disclosed.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.